Akèy › Adenokasinom Ezofajyen › New York
Etid klinik pou Adenokasinom Ezofajyen nan New York
20 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan New York.
Vil nan New York
- New York City18 etid
- Queens9 etid
- Greenburgh5 etid
- Rochester5 etid
- Buffalo3 etid
- New Rochelle3 etid
- The Bronx3 etid
Tèks ofisyèl etid la (Anglè)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Northwell Health Imbert Cancer Center, Bay Shore
- Roswell Park Cancer Institute, Buffalo
- Northwell Health Cancer Institute at Huntington, Greenlawn
- ak 7 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- The New York Hospital Medical Center of Queens, Flushing
- Glens Falls Hospital, Glens Falls
- ak 13 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Memorial Sloan-Kettering Cancer Center, New York
- New York Cancer & Blood Specialists, Shirley
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06324357A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
- Memorial Sloan Kettering Cancer Center, New York
- Local Institution - 0274, Rochester
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07221149Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Memorial Sloan Kettering Cancer Center Pharmacy (IMP ship to address), Long Island City
- Memorial Sloan Kettering Cancer Center Pharmacy (IMP storage location), Long Island City
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- ak 2 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
- New York Oncology Hematology, Albany
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07546812A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07818018Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Long Island Jewish Medical Center, Manhasset
- Columbia Universtiy, New York
- University of Rochester Medical Center, Rochester
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou Sep 11, 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, New York
- Research Site, New York
- Research Site, New York
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07431281A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
- Clinical Research Alliance, Inc, Westbury
- ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- START New York, Lake Success
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06657144A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
- ak 7 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Long Island Jewish Medical Center, New Hyde Park
- Weill Cornell Medicine, New York
- University of Rochester, Rochester
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou Jul 1, 2026 · NCT05530343First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT07284186Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT06340711Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT04900818A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 11, 2026 · NCT06623396Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- Roswell Park Cancer Institute, Buffalo
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 2, 2026 · NCT04682158Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
- Roswell Park Cancer Institute, Buffalo
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 16, 2025 · NCT05651594Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.